Időskori makuladegeneráció: vizsgálatok itt: Grúzia

2 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.

• 2. fázisTaking people
  A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

  Where

  Tbilisi

  Életkor

  55 év to 64 év

  People

  110 worldwide

  Run by

  Galimedix Therapeutics Inc

  See details and how to joinNCT06659549 · EU 2024-519128-26-00
• 1. fázisTaking people
  Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

  Where

  Tbilisi

  Életkor

  50 év and over

  People

  54 worldwide

  Run by

  Regeneron Pharmaceuticals

  See details and how to joinNCT07230834 · EU 2025-521758-40-00